Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations

Primary resistant Hodgkin lymphoma is an aggressive disease with few treatment options and short survival. Neoplastic cells of classical Hodgkin lymphoma are heavily dependent on microenvironmental stimuli, regularly express PD-L1, and a relevant proportion of relapsed patients is sensitive to block...

Descripción completa

Detalles Bibliográficos
Autores principales: Greil, Richard, Pleyer, Lisa, Jansko, Bettina, Feierabend, Carmen, Rettenbacher, Lukas, Stiefel, Olga, Rass, Christoph, Morre, Patrick, Neureiter, Daniel, Greil-Ressler, Sigrun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945535/
https://www.ncbi.nlm.nih.gov/pubmed/29755699
http://dx.doi.org/10.18632/oncotarget.25037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945535/
https://www.ncbi.nlm.nih.gov/pubmed/29755699
http://dx.doi.org/10.18632/oncotarget.25037

Ejemplares similares